MedTrace Logo

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

NCT04191213 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-01-28

No results posted yet for this study

Summary

To study the efficacy of Gum Arabic as an anti-oxidant, anti-inflammatory and Fetal Hemoglobin-inducing agent among Sickle Cell Disease children. Half of participants will receive Gum Arabic and the other half will receive placebo

Conditions

  • Sickle Cell Anemia in Children

Interventions

DIETARY_SUPPLEMENT

Acacia Senegal extract

Oral Digestion of Gum Arabic to be consumed early morning in daily basis for 12 weeks

DIETARY_SUPPLEMENT

Pectin

Oral Digestion of Pectin to be consumed early morning in daily basis for 12 weeks

Sponsors & Collaborators

  • University of Khartoum

    collaborator OTHER

  • Al-Neelain University

    lead OTHER

Principal Investigators

  • Imad M Fdl-Elmula, PhD · Alneelain University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-15
Primary Completion
2020-06-15
Completion
2020-07-15

Countries

  • Sudan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191213 on ClinicalTrials.gov